FDA-Drug2024-05-01Class III
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Hazard
Cross Contamination with Other Products
Sold states
USA nationwide.
Affected count
N/A
Manufactured in
224-18, Kawauchi-Cho, Tokushima, N/A, Japan
Products
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0469-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief